Skip to main content

Table 2 Characteristics of published studies of home- and community-based treatment for malaria in Africaa

From: Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence

Location

Epidemiology

Drug distribution

Incentive

Outcomes measured

Results

Kenya

1981–83

(Spencer et al, 1987a, 1987b)

• Rural

• Hyper- to holo-endemic

• CHWs provided presumptive CQ treatment for free

• Volunteer CHWs supported by the village

• Overall and malaria-specific mortality

• Birth and fertility rates

• Parasite rates

No obvious effect of providing CQ for treatment of malaria on mortality, fertility, or parasite rates

The Gambia

1982–87

(Greenwood et al, 1988; Menon et al, 1990)

• Rural

• Seasonal transmission

• CHWs sold CQ for presumptive treatment

• Volunteer CHWs supported by the village

• Overall and malaria-related mortality

• Frequency of clinical malaria

• Packed cell volume, parasite rates, splenomegaly

Treatment alone had no significant effect on morbidity and mortality from malaria

Zaire (DRC)

1985–87

(Delacollette et al, 1996)

• Rural

• Meso-endemic

• Continuous transmission with seasonal fluctuations

• CHWs sold CQ at cost for presumptive treatment

• CHWs received "symbolic monetary reward"

• Malaria morbidity and mortality

• Parasitological indices

• Proportion of fever episodes receiving antimalarial treatment, proportion receiving treatment at home, and source of treatment

No impact on malaria mortality, but two-fold reduction in malaria prevalence and incidence

Burkina Faso 1994–95

(Pagnoni et al, 1997)

• Rural

• Seasonal transmission

• Mothers trained to recognize illness and make decision to treat

• CHWs sold pre-packaged CQ for presumptive treatment

• CHWs kept 0.6 US cents for each package sold

• Proportion of under-5 malaria cases recorded as severe in health centres

• Mothers' care-seeking practices

• Availability and use of drugs at peripheral level, community awareness of educational messages

The proportion of severe cases decreased in the first year of the program; in the second year, the proportion decreased only in health facilities with drug coverage ≥50%

Ethiopia

1996–98

(Kidane and Morrow, 2000)

• Rural

• Seasonal transmission

• Mother coordinators provided presumptive CQ treatment for free

• None mentioned

• Malaria-related mortality in children under age 5 years

Intervention associated with 40.6% reduction in overall under-5 mortality (95% CI 29.2–50.6, p < 0.003)

Burkina Faso

1998–99

(Sirima et al, 2003)

• Rural

• Hyperendemic

• Seasonal transmission

• Mothers trained to recognize illness and make decision to treat

• CHWs sold pre-packaged CQ for presumptive treatment

• Drugs sold with 10% incentive margin for CHW

• Incentive provided to some drug store managers

• Proportion of malaria cases progressing to severe (as reported by mothers in annual cross-sectional surveys)

• Proportion of cases receiving correct dose of CQ

Risk of progression to severe malaria lower in children treated promptly with pre-packaged CQ (5%) than not (11%) (RR 0.47, 95% CI 0.37–0.60, p < 0.0001)

  1. aCHW = community health worker; CQ = chloroquine; RR = risk ratio